Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental Disorders

Anavex Life Sciences Provides an Update on Rett Syndrome Program

Anavex Announces First Entire Clinical Gene Pathway Data of ANAVEX®2-73 from AVATAR Study in Patients with Rett Syndrome